In an investigator-initiated study, @HopkinsMedicine researchers found patients with chronic skin lupus who took the systemic lupus drug anifrolumab were less likely to be hospitalized or develop skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results